Valuation
- Market cap
- 315,753,000
- Revenue TTM
- $0
- Net income TTM
- $-3,190,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 8.78
Trading
- Volume
- 19,236
- Avg volume
- 113,842
- Day's range
- $10.85 – $11.85
- Shares out
- 29,788,000
- Stochastic %K
- 26%
- Beta
- —
- Analysts
- Strong Sell
- Price target
- $25.00
Company profile
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company...
Show more
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 818 546 4011
- Website
- https://turntherapeutics.com
- Address
- 250 N Westlake Blvd, STE 210, Westlake Village, United States
Latest news
No headlines yet.
